Quarterly Financial Watch for Loxo Oncology, Inc. (NASDAQ:LOXO)


Quarterly Sales and EPS Roundup:

Loxo Oncology, Inc. (LOXO) reported earning per shares for the quarter ending Nov 02 BMO at -1.12, whereas, 7 number of analysts estimated the mean EPS at -1.22. The analysts estimated EPS for the higher end at -1.05 and lower end at -1.43 while the year ago reported earnings per share was -0.84.

The company has mean EPS estimate of -1.22 reported by 4 number of analyst for the quarter ending Current Qtr.(Dec2017). The analysts estimated mean EPS at -1.22 while the high and low EPS estimate stand at -1.05 and -1.33 respectively.

Valuation Ratios of Loxo Oncology, Inc. (LOXO) versus the Industry and Sector:

Let’s have a look at some of the important valuation ratios of the Loxo Oncology, Inc. (LOXO). These ratios are important while doing valuation of the company or the shares of the company.

Loxo Oncology, Inc. (LOXO) currently the company’s industry has 179.5 P/E and the sector P/E is 33.34. The industry’s and sector’s  high P/E for the past year is 287.99 and 45.04 respectively and low P/E ratio for the last 5 years is 94.57 for the industry and 24.16 for the Sector.

Beta is also an important valuation ratio for analyzing the stock of the company, LOXO has its industry and Sector’s beta remains at 0.85 and 0.89 respectively.

The Price to Book Ratio stands at 6.32. The industry and sector ratio of Price to Cash Flow ticked at 89.03 and 22.96 respectively.

5 Year Growth Rate Analysis:

Growth rates are very important while analyzing the long term growth and valuation of a certain company.

5 year sales growth rate is an important factor for valuation analysis, the industry’s and the sector’s growth for next 5 years ticked at 32.74 and 10.33 respectively.

Loxo Oncology, Inc. (LOXO) Trading Statistics:

The company declined -4.07% and closed its last trading session at $83.23. The market capitalization of the company is at $2.36 Billion. The stock touched 52-week High of $95.92 on 09/28/17 and 52-week Low of $25.25 on 12/14/16. The stock currently has Weekly Volatility of 6.00% and Monthly Volatility of 4.76%. The Beta Average True Range (ATR) shows a value of 4.38.